Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 176,916 |
|
|||||
| News | - | ||||||
| Day High | 3.92 | Low High |
|||||
| Day Low | 3.51 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Maia Biotechnology Inc | MAIA | AMEX | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.2686 | -7.11% | 3.5114 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.77 | 3.51 | 3.92 | 3.54 | 3.78 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 978 | 176,916 | US$ 3.71 | US$ 656,126 | - | 0.82 - 5.99 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 11,090 | US$ 3.54 | USD |
Maia Biotechnology Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 50.03M | 14.21M | - | 0 | -19.77M | -1.39 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Maia Biotechnology News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/07/2024 | 11:31 | Business Wire | MAIA Biotechnology's Telomere Targeting Functionality is.. |
| 6/06/2024 | 13:57 | Edgar (US Regulatory) | Form 8-K - Current report |
| 6/06/2024 | 09:07 | Business Wire | MAIA Biotechnology Announces Year-to-Date Achievements and.. |
| 6/04/2024 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 6/04/2024 | 07:41 | Business Wire | MAIA Biotechnology Reveals New Clinical Data Showing THIO’s.. |
| 6/03/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/29/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/17/2024 | 07:37 | Business Wire | MAIA Biotechnology to Present at the BIO International.. |
| 5/16/2024 | 07:37 | Business Wire | MAIA Biotechnology Abstract Accepted for Poster Presentation.. |
| 5/15/2024 | 15:07 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/15/2024 | 15:05 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 5/14/2024 | 15:11 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MAIA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.85 | 4.10 | 3.51 | 3.84 | 385,123 | -0.3386 | -8.79% |
| 1 Month | 3.71 | 5.99 | 3.05 | 3.96 | 564,441 | -0.1986 | -5.35% |
| 3 Months | 2.58 | 5.99 | 1.851 | 3.37 | 378,549 | 0.9314 | 36.10% |
| 6 Months | 1.06 | 5.99 | 0.95 | 2.39 | 396,943 | 2.45 | 231.26% |
| 1 Year | 2.20 | 5.99 | 0.82 | 2.19 | 301,510 | 1.31 | 59.61% |
| 3 Years | 4.10 | 9.64 | 0.82 | 3.41 | 247,611 | -0.5886 | -14.36% |
| 5 Years | 4.10 | 9.64 | 0.82 | 3.41 | 247,611 | -0.5886 | -14.36% |
Maia Biotechnology Description
| MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells. |
